Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Angiogenesis is an established prognostic factor in advanced breast cancer, yet response to antiangiogenic therapies in this disease remains highly variable. Noninvasive imaging biomarkers could help identify patients that will benefit from antiangiogenic therapy and provide an ideal tool for longit...

Descripción completa

Detalles Bibliográficos
Autores principales: Quiros-Gonzalez, Isabel, Tomaszewski, Michal R., Golinska, Monika A., Brown, Emma, Ansel-Bollepalli, Laura, Hacker, Lina, Couturier, Dominique-Laurent, Sainz, Rosa M., Bohndiek, Sarah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Convergence and Technologies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359720/
https://www.ncbi.nlm.nih.gov/pubmed/35404400
http://dx.doi.org/10.1158/0008-5472.CAN-21-0626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359720/
https://www.ncbi.nlm.nih.gov/pubmed/35404400
http://dx.doi.org/10.1158/0008-5472.CAN-21-0626

Ejemplares similares